Nursing care
Bone Density Screening, explained for the bedside and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Bone density screening begins at 65 for women, earlier if risk factors are present, using dual-energy X-ray absorptiometry (DXA). The result is reported as a T-score: normal above -1.0, osteopenia between -1.0 and -2.5, and osteoporosis at -2.5 or below. The score drives whether the plan is prevention, monitoring, or treatment.
What the concept actually says
Bone density screening measures bone mineral density, usually at the hip and lumbar spine, using a DXA scan. The result is expressed as a T-score, which compares the patient's bone density to that of a healthy young adult of the same sex. A T-score above -1.0 is normal, -1.0 to -2.5 is osteopenia, and -2.5 or below is osteoporosis.
Screening starts at 65 for women, reflecting the steep bone loss that follows menopause and the resulting fracture risk. Earlier screening is indicated for women under 65 with risk factors: low body weight, prior fracture as an adult, smoking, long-term corticosteroid use, a family history of hip fracture, or a condition like rheumatoid arthritis. Men are screened later and less routinely, usually from 70 or earlier with similar risk factors, since their bone loss trajectory differs.
A Z-score also appears on some reports. It compares the patient to others of the same age, sex, and body size, and is used mainly in younger patients or when a secondary cause of bone loss is suspected. The T-score, not the Z-score, is what stages osteoporosis and drives treatment thresholds.
The clinical reasoning behind it
The rationale for timing screening at 65 is fracture prevention, not the density number itself. Hip and vertebral fractures in older adults carry high morbidity and a meaningful risk of death within the following year, so the goal is to identify low bone density before a fracture forces the diagnosis.
Risk factors that justify earlier screening work because they accelerate bone loss or predict fragility independent of age. Corticosteroids suppress osteoblast activity directly. Low body weight means less mechanical loading on bone and less peripheral estrogen conversion in fat tissue. A prior fragility fracture is one of the strongest predictors of a second fracture, which is why it triggers screening regardless of age.
The T-score threshold of -2.5 is not arbitrary. It was set because fracture risk rises sharply below that point, and it aligns with when pharmacologic treatment, such as a bisphosphonate, becomes cost-effective relative to the risk of harm. Osteopenia sits in a grey zone: monitoring and lifestyle modification are usually the first response, with treatment considered case by case using tools like FRAX to estimate 10-year fracture risk.
Applying it under time pressure
When a question gives an age and a T-score, resolve the T-score first. A postmenopausal woman with a T-score of -2.6 has osteoporosis regardless of how healthy she otherwise appears, and the expected nursing response is fall-risk precautions, calcium and vitamin D counselling, and reinforcing the prescriber's plan for pharmacologic treatment.
If the stem describes a younger patient, say 50, on long-term prednisone for lupus, that is your cue for early screening rather than waiting for age 65. Match the risk factor to the action: corticosteroid use means screen now, not at the standard interval.
Watch for the trap where age alone is presented without a T-score. Age 65 is the trigger for screening, not a diagnosis. Do not select an intervention that assumes osteoporosis is confirmed unless the T-score is given or explicitly described as diagnostic.
Common misconceptions
A common error is treating DXA screening as universal at a fixed age for everyone. It is universal for women at 65, but for men and for younger at-risk patients, screening is triggered by risk factors, not a birthday.
Another is confusing osteopenia with osteoporosis. Osteopenia is a T-score of -1.0 to -2.5 and generally calls for lifestyle measures and monitoring, not automatic drug therapy. Selecting a bisphosphonate for a patient described only as having osteopenia is a frequent wrong answer.
Students also sometimes assume a normal DXA result rules out future fracture risk permanently. Bone density changes over time, particularly with new risk factors such as a fall, a new corticosteroid prescription, or menopause onset, so a single normal scan does not close the question.
Practice scenarios
A 68-year-old woman has a DXA T-score of -2.7 at the hip. She should be counselled on fall prevention, adequate calcium and vitamin D intake, weight-bearing exercise, and adherence to prescribed pharmacologic therapy, since her score confirms osteoporosis.
A 45-year-old woman with rheumatoid arthritis on long-term prednisone asks why she needs a bone density scan now. The correct explanation centres on corticosteroid-induced bone loss as an independent risk factor that moves screening earlier than the standard age of 65.
A 60-year-old man with no risk factors asks about bone density screening. The appropriate response acknowledges that routine screening for men typically begins later, around 70, unless he has risk factors such as prior fracture, low testosterone, or corticosteroid use.
Key takeaways
Screening for women begins at 65, or earlier with risk factors such as low body weight, prior fracture, smoking, corticosteroid use, or family history of hip fracture.
The T-score stages the result: above -1.0 is normal, -1.0 to -2.5 is osteopenia, -2.5 or below is osteoporosis, and it is the T-score, not age alone, that should drive the nursing response in a scenario.
Nursing interventions scale with severity: fall-risk precautions and calcium and vitamin D counselling apply broadly, while pharmacologic therapy is reserved for confirmed osteoporosis or high fracture-risk osteopenia.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our health promotion practice questions are the closest set to what this page covers.
One question from the health promotion set
A client at 30 weeks' gestation reports a headache that will not resolve, blurred vision, and swelling of the hands. Blood pressure is 158/104 mm Hg. Which action should the nurse take first?
Rationale
Headache that will not resolve, visual changes, and a blood pressure of 158/104 after 20 weeks are severe features of preeclampsia — the client is at risk of seizing. Notify and prepare for magnesium sulfate, which is given for seizure prophylaxis rather than for the blood pressure itself. Resting and rechecking in an hour delays treatment, and a urine culture answers a different question entirely.
Answer: B
Common questions
At what age should bone density screening start for women?
Routine screening starts at 65. It should start earlier if the woman has risk factors such as a prior fragility fracture, low body weight, smoking, long-term corticosteroid use, or a family history of hip fracture.
What T-score confirms osteoporosis?
A T-score of -2.5 or below confirms osteoporosis. A T-score between -1.0 and -2.5 is osteopenia, and above -1.0 is normal bone density.
Is the T-score or the Z-score used to diagnose osteoporosis?
The T-score is used. It compares the patient's bone density to a healthy young adult reference, which is what the diagnostic thresholds are built around. The Z-score compares age-matched peers and is used mainly to investigate secondary causes in younger patients.
Do men need bone density screening?
Yes, though generally starting later than women, often around 70, or earlier if risk factors such as prior fracture, hypogonadism, or long-term corticosteroid use are present.
Does osteopenia always require medication?
No. Osteopenia usually prompts lifestyle measures, calcium and vitamin D intake, and monitoring rather than automatic pharmacologic treatment. Medication is considered when fracture risk assessment tools indicate high 10-year risk despite the intermediate T-score.